| Mesenchymal stem cells deliver exogenous microRNA-let7c via exosomes to attenuate renal fibrosis B Wang, K Yao, BM Huuskes, HH Shen, J Zhuang, C Godson, ... Molecular therapy 24 (7), 1290-1301, 2016 | 346 | 2016 |
| Retinal neovascularization is prevented by blockade of the renin-angiotensin system CJ Moravski, DJ Kelly, ME Cooper, RE Gilbert, JF Bertram, S Shahinfar, ... Hypertension 36 (6), 1099-1104, 2000 | 273 | 2000 |
| Protein kinase C β inhibition attenuates the progression of experimental diabetic nephropathy in the presence of continued hypertension DJ Kelly, Y Zhang, C Hepper, RM Gow, K Jaworski, BE Kemp, ... Diabetes 52 (2), 512-518, 2003 | 255 | 2003 |
| Neuronal and glial cell abnormality as predictors of progression of diabetic retinopathy EL Fletcher, JA Phipps, MM Ward, T Puthussery, JL Wilkinson-Berka Current pharmaceutical design 13 (26), 2699-2712, 2007 | 254 | 2007 |
| Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes RE Gilbert, DJ Kelly, AJ Cox, JL Wilkinson-Berka, JR Rumble, T Osicka, ... Diabetologia 43, 1360-1367, 2000 | 236 | 2000 |
| Vascular endothelial growth factor and its receptors in control and diabetic rat eyes. RE Gilbert, D Vranes, JL Berka, DJ Kelly, A Cox, LL Wu, SA Stacker, ... Laboratory investigation; a journal of technical methods and pathology 78 (8 …, 1998 | 235 | 1998 |
| Vasoactive factors and diabetic retinopathy: vascular endothelial growth factor, cycoloxygenase-2 and nitric oxide JL Wilkinson-Berka Current pharmaceutical design 10 (27), 3331-3348, 2004 | 220 | 2004 |
| Podocyte foot process broadening in experimental diabetic nephropathy: amelioration with renin-angiotensin blockade SA Mifsud, TJ Allen, JF Bertram, UL Hulthen, DJ Kelly, ME Cooper, ... Diabetologia 44, 878-882, 2001 | 213 | 2001 |
| Angiotensin and diabetic retinopathy JL Wilkinson-Berka The international journal of biochemistry & cell biology 38 (5-6), 752-765, 2006 | 211 | 2006 |
| A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2) 27 rat (TGR) DJ Kelly, JL Wilkinson-Berka, TJ Allen, ME Cooper, SL Skinner Kidney International 54 (2), 343-352, 1998 | 201 | 1998 |
| Oxidative stress and reactive oxygen species: a review of their role in ocular disease L Ung, U Pattamatta, N Carnt, JL Wilkinson-Berka, G Liew, AJR White Clinical Science 131 (24), 2865-2883, 2017 | 193 | 2017 |
| Identification of a retinal aldosterone system and the protective effects of mineralocorticoid receptor antagonism on retinal vascular pathology JL Wilkinson-Berka, G Tan, K Jaworski, J Harbig, AG Miller Circulation research 104 (1), 124-133, 2009 | 188 | 2009 |
| Retinal angiogenesis is mediated by an interaction between the angiotensin type 2 receptor, VEGF, and angiopoietin S Sarlos, B Rizkalla, CJ Moravski, Z Cao, ME Cooper, JL Wilkinson-Berka The American journal of pathology 163 (3), 879-887, 2003 | 179 | 2003 |
| ALT-946 and aminoguanidine, inhibitors of advanced glycation, improve severe nephropathy in the diabetic transgenic (mREN-2) 27 rat JL Wilkinson-Berka, DJ Kelly, SM Koerner, K Jaworski, B Davis, V Thallas, ... Diabetes 51 (11), 3283-3289, 2002 | 176 | 2002 |
| Renin-containing Müller cells of the retina display endocrine features. JL Berka, AJ Stubbs, DZ Wang, R DiNicolantonio, D Alcorn, DJ Campbell, ... Investigative ophthalmology & visual science 36 (7), 1450-1458, 1995 | 172 | 1995 |
| Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy: implications for the pathogenesis of tubulointerstitial fibrosis RE Gilbert, LL Wu, DJ Kelly, A Cox, JL Wilkinson-Berka, CI Johnston, ... The American journal of pathology 155 (2), 429-440, 1999 | 171 | 1999 |
| The renin–angiotensin system in retinal health and disease: its influence on neurons, glia and the vasculature EL Fletcher, JA Phipps, MM Ward, KA Vessey, JL Wilkinson-Berka Progress in retinal and eye research 29 (4), 284-311, 2010 | 168 | 2010 |
| Reactive oxygen species, Nox and angiotensin II in angiogenesis: implications for retinopathy JL Wilkinson-Berka, I Rana, R Armani, A Agrotis Clinical science 124 (10), 597-615, 2013 | 167 | 2013 |
| Tranilast attenuates cardiac matrix deposition in experimental diabetes: role of transforming growth factor-β J Martin, DJ Kelly, SA Mifsud, Y Zhang, AJ Cox, F See, H Krum, ... Cardiovascular research 65 (3), 694-701, 2005 | 156 | 2005 |
| Inhibition of platelet-derived growth factor promotes pericyte loss and angiogenesis in ischemic retinopathy JL Wilkinson-Berka, S Babic, T De Gooyer, AW Stitt, K Jaworski, LGT Ong, ... The American journal of pathology 164 (4), 1263-1273, 2004 | 156 | 2004 |
